Clinical Trial Update: Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) [Phase 4]

View source ↗

Summary

Phase 4 study comparing intraocular pressure control in open-angle glaucoma or ocular hypertension patients treated with travoprost 0.004% versus bimatoprost 0.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Bimatoprost 0.01% (LUMIGAN) (Bimatoprost)
• Travoprost 0.004% (Travatan Z) (Travoprost)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2013-09-04